Many clinicians build Medical Devices that solve real clinical problems.

They secure regulatory approval.

They get positive feedback from early users.

They even generate interest from hospitals or distributors.

And yet… adoption stalls.

Not because the product is poor — but because something critical in the launch is structurally weak.

In this episode, we break down the four Ps that determine whether a MedTech product gets adopted or simply admired.

This is not textbook marketing theory.

It’s the real-world framework that reveals exactly where your go-to-market strategy is breaking down.

You’ll discover:

1. Why regulatory approval and engineering perfection don’t guarantee adoption
2. The difference between clinical enthusiasm and commercial proof
3. Why hospitals buy through processes — not passion
4. The hidden influence of decision-making units inside healthcare systems
5. Why distributors and internal teams must align around the same commercial structure

If you’re a clinician trying to turn a working prototype into a scalable Medical Device business, this framework will help you quickly identify the structural weakness slowing your launch.

Because technically strong MedTech products rarely fail due to innovation.

They fail when one of the four Ps breaks down.

In the episode, we also walk through a quick self-audit so you can score your own launch and identify the single area that could unlock momentum in the next 90 days.

Listen now and see where your go-to-market strategy might be exposed.

Message me via DM on Linkedin

Book a 30 min discovery call for the Healthcare Export Accelerator Programme

This podcast is for clinicians turning medical devices into real businesses, with practical insight on go to market strategy, exporting, and scaling in international MedTech.